11,000 Shares in Xenetic Biosciences Inc (NASDAQ:XBIO) Purchased by LGT Group Foundation

LGT Group Foundation acquired a new stake in shares of Xenetic Biosciences Inc (NASDAQ:XBIO) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 11,000 shares of the company’s stock, valued at approximately $41,000.

Xenetic Biosciences Trading Down 1.8 %

Shares of XBIO opened at $3.99 on Wednesday. The company has a market cap of $6.14 million, a price-to-earnings ratio of -1.50 and a beta of 2.17. The business’s fifty day simple moving average is $4.11 and its two-hundred day simple moving average is $4.03. Xenetic Biosciences Inc has a 12 month low of $2.78 and a 12 month high of $5.20.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “neutral” rating on shares of Xenetic Biosciences in a report on Thursday, December 5th.

Xenetic Biosciences Company Profile

Xenetic Biosciences, Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas.